524 related articles for article (PubMed ID: 35468749)
1. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
[TBL] [Abstract][Full Text] [Related]
2. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
[TBL] [Abstract][Full Text] [Related]
3. Detection of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs According to Viral Variants.
Salmona M; Chaix ML; Feghoul L; Mahjoub N; Maylin S; Schnepf N; Jacquier H; Walle EM; Helary M; Mellon G; Osinski N; Zebiche W; Achili Y; Amarsy R; Mahé V; Le Goff J; Delaugerre C
Microbiol Spectr; 2022 Dec; 10(6):e0213322. PubMed ID: 36346252
[TBL] [Abstract][Full Text] [Related]
4. Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon.
AlKalamouni H; Abou Hassan FF; Bou Hamdan M; Page AJ; Lott M; Matthews M; Ghosn N; Rady A; Mahfouz R; Araj GF; Dbaibo G; Zaraket H; Melhem NM; Matar GM
BMC Med Genomics; 2023 Jan; 16(1):14. PubMed ID: 36707851
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant.
Rosato AE; Msiha E; Weng B; Mesisca M; Gnass R; Gnass S; Bol C; Tabuenca A; Rosato RR
Pathology; 2022 Apr; 54(3):351-356. PubMed ID: 35221043
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
7. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
8. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
Borillo GA; Kagan RM; Marlowe EM
Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
[TBL] [Abstract][Full Text] [Related]
10. A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan.
Kairov U; Amanzhanova A; Karabayev D; Rakhimova S; Aitkulova A; Samatkyzy D; Kalendar R; Kozhamkulov U; Molkenov A; Gabdulkayum A; Sarbassov D; Akilzhanova A
Front Genet; 2022; 13():906318. PubMed ID: 36118859
[TBL] [Abstract][Full Text] [Related]
11. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.
Carbo EC; Mourik K; Boers SA; Munnink BO; Nieuwenhuijse D; Jonges M; Welkers MRA; Matamoros S; van Harinxma Thoe Slooten J; Kraakman MEM; Karelioti E; van der Meer D; Veldkamp KE; Kroes ACM; Sidorov I; de Vries JJC
Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):701-713. PubMed ID: 37017810
[TBL] [Abstract][Full Text] [Related]
12. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.
Guerrero-Preston R; Rivera-Amill V; Caraballo K; Rodríguez-Torres S; Purcell-Wiltz A; García AA; Torres RS; Zamuner FT; Zanettini C; MacKay MJ; Baits R; Salgado D; Khullar G; Metti J; Baker T; Dudley J; Vale K; Pérez G; De Jesús L; Miranda Y; Ortiz D; García-Negrón A; Viera L; Ortiz A; Canabal JA; Romaguera J; Jiménez-Velázquez I; Marchionni L; Rodríguez-Orengo JF; Baez A; Mason CE; Sidransky D
Immun Inflamm Dis; 2022 Jun; 10(6):e634. PubMed ID: 35634961
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA's GenomeTrakr network.
Timme RE; Woods J; Jones JL; Calci KR; Rodriguez R; Barnes C; Leard E; Craven M; Chen H; Boerner C; Grim C; Windsor AM; Ramachandran P; Muruvanda T; Rand H; Tesfaldet B; Amirzadegan J; Kayikcioglu T; Walsky T; Allard M; Balkey M; Bias CH; Brown E; Judy K; Pfefer T; Tallent SM; Hoffmann M; ; Pettengill J
mSystems; 2024 Jun; 9(6):e0141523. PubMed ID: 38819130
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Next Generation Sequencing (NGS) data from clinical isolates from the East Texas Region of the United States.
Carpenter RE; Tamrakar VK; Almas S; Sharma A; Sharma R
Data Brief; 2023 Aug; 49():109312. PubMed ID: 37346925
[TBL] [Abstract][Full Text] [Related]
15. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
PeerJ; 2022; 10():e13132. PubMed ID: 35341058
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
[TBL] [Abstract][Full Text] [Related]
17. Efficient SARS-CoV-2 Surveillance during the Pandemic-Endemic Transition Using PCR-Based Genotyping Assays.
Koets L; van Leeuwen K; Derlagen M; van Wijk J; Keijzer N; Feenstra JDM; Gandhi M; Sorel O; van de Laar TJW; Koppelman MHGM
Microbiol Spectr; 2023 Jun; 11(3):e0345022. PubMed ID: 37154727
[TBL] [Abstract][Full Text] [Related]
18. An Upgrade on the Surveillance System of SARS-CoV-2: Deployment of New Methods for Genetic Inspection.
Muñoz-Valle JF; Venancio-Landeros AA; Sánchez-Sánchez R; Reyes-Díaz K; Galindo-Ornelas B; Hérnandez-Monjaraz WS; García-Ríos A; García-Ortega LF; Hernández-Bello J; Peña-Rodríguez M; Vega-Magaña N; Delaye L; Díaz-Sánchez M; García-González OP
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328562
[TBL] [Abstract][Full Text] [Related]
19. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
[TBL] [Abstract][Full Text] [Related]
20. Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis.
Asante IA; Hsu SN; Boatemaa L; Kwasah L; Adusei-Poku M; Odoom JK; Awuku-Larbi Y; Foulkes BH; Oliver-Commey J; Asiedu EK; Parker MD; Mitja O; Eggo RM; de Oliveira-Martins L; Asiedu-Bekoe F; Laryea DO; Kuma-Aboagye P; Marks M; de Silva TI; Ampofo WK
Lancet Glob Health; 2023 Jul; 11(7):e1075-e1085. PubMed ID: 37349034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
